Connection

Michael von Bergwelt-Baildon to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about Combined Modality Therapy.
Michael von Bergwelt-Baildon
Connection Strength
0.167
Combined Modality Therapy
  1. Advances in cancer immunotherapy 2019 - latest trends. J Exp Clin Cancer Res. 2019 Jun 19; 38(1):268.
    View in: PubMed
    Score: 0.100
  2. S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86). J Dtsch Dermatol Ges. 2018 Jan; 16(1):112-122.
    View in: PubMed
    Score: 0.023
  3. Should we be combining local tumor therapies with immunotherapies as standard? Future Oncol. 2017 08; 13(18):1573-1575.
    View in: PubMed
    Score: 0.022
  4. Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors. Immunotherapy. 2017 03; 9(5):423-433.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.